The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

Edwards Lifesciences reports 8% Q1 2025 sales growth to $1.41B, driven by TAVR & TMTT. Discover regulatory catalysts & future growth insights.

A St. Louis-based company has added to its holdings in the environmental monitoring sector with the addition of a California company.

Edwards Lifesciences raised its 2025 sales forecast on Wednesday after a quarterly beat, driven by robust demand for its artificial heart valves and other medical equipment.

Colliers, a commercial real estate services firm, recently did its second annual analysis of the top life sciences hubs in ...

The rise of life science startups is revolutionizing healthcare, leveraging biotechnology to address critical health ...

As Komodo celebrates over a decade of innovation in its mission to reduce the burden of disease, The One Day Summit will also spotlight how the company is setting the new standard for healthcare ...